Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
88205002 |
LAW OFFICE ASSIGNED |
LAW OFFICE 120 |
MARK SECTION |
MARK |
http://uspto.report/TM/88205002/mark.png |
LITERAL ELEMENT |
SNAP |
STANDARD CHARACTERS |
YES |
USPTO-GENERATED IMAGE |
YES |
MARK STATEMENT |
The mark consists of standard characters, without claim to any particular font style, size or color. |
EVIDENCE SECTION |
EVIDENCE FILE NAME(S) |
ORIGINAL PDF FILE |
evi_502421257-20190819105610347836_._ESX-T065_Response_Non-Final_Office_Action_Exhibit_A.pdf |
CONVERTED PDF FILE(S)
(2 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\882\050\88205002\xml4\ROA0002.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\882\050\88205002\xml4\ROA0003.JPG |
ORIGINAL PDF FILE |
evi_1-502421257-20190819105610347836_._ESX-T065_Response_Non-Final_Office_Action_FINAL.pdf |
CONVERTED PDF FILE(S)
(4 pages) |
\\TICRS\EXPORT17\IMAGEOUT17\882\050\88205002\xml4\ROA0004.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\882\050\88205002\xml4\ROA0005.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\882\050\88205002\xml4\ROA0006.JPG |
|
\\TICRS\EXPORT17\IMAGEOUT17\882\050\88205002\xml4\ROA0007.JPG |
DESCRIPTION OF EVIDENCE FILE |
The evidence consists of Applicant's Response and Exhibit to the Non-Final Office Action of February 27, 2019. |
GOODS AND/OR SERVICES SECTION (010)(current) |
INTERNATIONAL CLASS |
010 |
DESCRIPTION |
Medical diagnostic apparatus for testing cells, tissue and biomolecules, in the nature of proteins, small molecules, cells, and nucleic
acids; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, in the fields of cancer,
blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology,
and cell-based testing; Devices for personal wellness, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and
diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic
instruments, namely, instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample |
FILING BASIS |
Section 1(b) |
GOODS AND/OR SERVICES SECTION (010)(proposed) |
INTERNATIONAL CLASS |
010 |
TRACKED TEXT DESCRIPTION |
Medical diagnostic apparatus for testing cells, tissue and biomolecules, in the nature of proteins, small molecules,
cells, and nucleic acids; Medical devices for obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of
bodily fluids; Medical apparatus for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, blood abnormalities, immune
diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing;
Medical apparatus for diagnostic use, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases,
infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; medical diagnostic
devices for personal wellness, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of
cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Devices
for personal wellness, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of
cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical
diagnostic instruments, namely, instruments for medical testing in the nature of the detection and identification of nucleic acids, namely, DNA and RNA in a sample; Medical diagnostic instruments, namely, instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample |
FINAL DESCRIPTION |
Medical diagnostic apparatus for testing cells, tissue and biomolecules, in the nature of proteins, small molecules, cells, and nucleic
acids; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, blood
abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and
cell-based testing; medical diagnostic devices for personal wellness, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health
conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases;
Medical diagnostic instruments, namely, instruments for medical testing in the nature of the detection and identification of nucleic acids, namely, DNA and RNA in a sample |
FILING BASIS |
Section 1(b) |
GOODS AND/OR SERVICES SECTION (044)(current) |
INTERNATIONAL CLASS |
044 |
DESCRIPTION |
Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic
testing, and tests for personal wellness, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases,
genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of nucleic acids, namely, DNA and RNA in a
sample |
FILING BASIS |
Section 1(b) |
GOODS AND/OR SERVICES SECTION (044)(proposed) |
INTERNATIONAL CLASS |
044 |
TRACKED TEXT DESCRIPTION |
Medical services, medical assistance, medical consultations, medical counseling, medical information,
healthcare testing, diagnostic testing, and tests for personal wellness, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases,
infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services, medical
assistance, medical counseling, healthcare testing, diagnostic testing, and diagnostic tests for personal wellness, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological
diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of nucleic acids, namely, DNA and RNA in a sample; Medical services for the detection and
identification of nucleic acids in a sample, namely, DNA and RNA screening for medical purposes; all of the aforesaid services not including medical
consultations provided via phone, online or videoconferencing and providing information about medical test results to patients and medical professionals in the form of reports |
FINAL DESCRIPTION |
Medical services, medical assistance, medical counseling, healthcare testing, diagnostic testing, and diagnostic tests for personal
wellness, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other
tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of nucleic acids in a sample, namely, DNA and RNA screening for medical
purposes; all of the aforesaid services not including medical consultations provided via phone, online or videoconferencing and providing information about medical test results to patients and
medical professionals in the form of reports |
FILING BASIS |
Section 1(b) |
ATTORNEY SECTION (current) |
NAME |
Julian D. Gonzalez |
ATTORNEY BAR MEMBERSHIP NUMBER |
NOT SPECIFIED |
YEAR OF ADMISSION |
NOT SPECIFIED |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
NOT SPECIFIED |
STREET |
1 DEERPARK DRIVE, SUITE R |
CITY |
MONMOUTH JUNCTION |
STATE |
New Jersey |
POSTAL CODE |
08852 |
COUNTRY |
US |
PHONE |
732-274-1020 |
FAX |
732-274-1021 |
EMAIL |
esxip@essenlix.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
ESX-T065 |
ATTORNEY SECTION (proposed) |
NAME |
Julian D. Gonzalez |
ATTORNEY BAR MEMBERSHIP NUMBER |
XXX |
YEAR OF ADMISSION |
XXXX |
U.S. STATE/ COMMONWEALTH/ TERRITORY |
XX |
STREET |
1 DEERPARK DRIVE, SUITE R |
CITY |
MONMOUTH JUNCTION |
STATE |
New Jersey |
POSTAL CODE |
08852 |
COUNTRY |
United States |
PHONE |
732-274-1020 |
FAX |
732-274-1021 |
EMAIL |
esxip@essenlix.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
ESX-T065 |
CORRESPONDENCE SECTION (current) |
NAME |
JULIAN D. GONZALEZ |
STREET |
1 DEERPARK DRIVE, SUITE R |
CITY |
MONMOUTH JUNCTION |
STATE |
New Jersey |
POSTAL CODE |
08852 |
COUNTRY |
US |
PHONE |
732-274-1020 |
FAX |
732-274-1021 |
EMAIL |
esxip@essenlix.com; julian_gonzalez@essenlix.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
ESX-T065 |
CORRESPONDENCE SECTION (proposed) |
NAME |
Julian D. Gonzalez |
STREET |
1 DEERPARK DRIVE, SUITE R |
CITY |
MONMOUTH JUNCTION |
STATE |
New Jersey |
POSTAL CODE |
08852 |
COUNTRY |
United States |
PHONE |
732-274-1020 |
FAX |
732-274-1021 |
EMAIL |
esxip@essenlix.com; julian_gonzalez@essenlix.com |
AUTHORIZED TO COMMUNICATE VIA EMAIL |
Yes |
DOCKET/REFERENCE NUMBER |
ESX-T065 |
SIGNATURE SECTION |
RESPONSE SIGNATURE |
/Julian D. Gonzalez/ |
SIGNATORY'S NAME |
Julian D. Gonzalez |
SIGNATORY'S POSITION |
Attorney of Record, New Jersey bar member |
SIGNATORY'S PHONE NUMBER |
732-274-1020 |
DATE SIGNED |
08/19/2019 |
AUTHORIZED SIGNATORY |
YES |
FILING INFORMATION SECTION |
SUBMIT DATE |
Mon Aug 19 12:08:55 EDT 2019 |
TEAS STAMP |
USPTO/ROA-XX.XXX.XX.XX-20
190819120855243451-882050
02-610b6cec1d71a926d5994e
f39f4878385486ff742ef99e9
5ddf2cde646aba19-N/A-N/A-
20190819105610347836 |
Under the Paperwork Reduction Act of 1995 no persons are required to respond to a collection of information unless it displays a valid OMB control number.
PTO Form 1957 (Rev 10/2011) |
OMB No. 0651-0050 (Exp 09/20/2020) |
Response to Office Action
To the Commissioner for Trademarks:
Application serial no.
88205002 SNAP(Standard Characters, see http://uspto.report/TM/88205002/mark.png) has been amended as follows:
EVIDENCE
Evidence in the nature of The evidence consists of Applicant's Response and Exhibit to the Non-Final Office Action of February 27, 2019. has been attached.
Original PDF file:
evi_502421257-20190819105610347836_._ESX-T065_Response_Non-Final_Office_Action_Exhibit_A.pdf
Converted PDF file(s) ( 2 pages)
Evidence-1
Evidence-2
Original PDF file:
evi_1-502421257-20190819105610347836_._ESX-T065_Response_Non-Final_Office_Action_FINAL.pdf
Converted PDF file(s) ( 4 pages)
Evidence-1
Evidence-2
Evidence-3
Evidence-4
CLASSIFICATION AND LISTING OF GOODS/SERVICES
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 010 for Medical diagnostic apparatus for testing cells, tissue and biomolecules, in the nature of proteins, small molecules, cells, and nucleic acids; Medical devices for
obtaining bodily fluid samples; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely, in the fields of cancer, blood abnormalities, immune
diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing;
Devices for personal wellness, namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of
cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic instruments, namely,
instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sample
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Proposed:
Tracked Text Description: Medical diagnostic apparatus for testing cells, tissue and biomolecules, in the nature of proteins, small molecules, cells, and nucleic
acids;
Medical devices for obtaining bodily fluid samples;
Medical diagnostic instruments for the analysis of bodily fluids;
Medical apparatus for diagnostic use, namely, apparatus for medical diagnostic testing in the fields of cancer, blood abnormalities, immune diseases, neurological
diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing;
Medical apparatus for diagnostic use, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral
diseases and genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing;
medical diagnostic devices for personal wellness,
namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities,
immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases;
Devices for personal wellness,
namely, point-of-care diagnostic devices, at-home diagnostic devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities,
immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic diseases;
Medical diagnostic instruments,
namely, instruments for medical testing in the nature of the detection and identification of nucleic acids, namely, DNA and RNA in a sample;
Medical diagnostic
instruments, namely, instruments for the detection and identification of nucleic acids, namely, DNA and RNA in a sampleClass 010 for Medical diagnostic apparatus for testing cells, tissue and
biomolecules, in the nature of proteins, small molecules, cells, and nucleic acids; Medical diagnostic instruments for the analysis of bodily fluids; Medical apparatus for diagnostic use, namely,
apparatus for medical diagnostic testing in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases and genetic
diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; medical diagnostic devices for personal wellness, namely, point-of-care diagnostic devices, at-home diagnostic
devices, and portable health monitoring devices that detect health conditions and diseases in the nature of cancers, blood abnormalities, immune diseases, neurological diseases, cardiovascular
diseases, infectious diseases, viral diseases and genetic diseases; Medical diagnostic instruments, namely, instruments for medical testing in the nature of the detection and identification of
nucleic acids, namely, DNA and RNA in a sample
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Applicant proposes to amend the following class of goods/services in the application:
Current: Class 044 for Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic testing, and tests for personal
wellness, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other
tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and identification of nucleic acids, namely, DNA and RNA in a sample
Original Filing Basis:
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
Proposed:
Tracked Text Description: Medical services, medical assistance, medical consultations, medical counseling, medical information, healthcare testing, diagnostic
testing, and tests for personal wellness, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular diseases, infectious diseases, viral diseases,
genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing;
Medical services, medical assistance, medical counseling,
healthcare testing, diagnostic testing, and diagnostic tests for personal wellness, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases, cardiovascular
diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing;
Medical services
for the detection and identification of nucleic acids, namely, DNA and RNA in a sample;
Medical services for the detection and identification of nucleic acids
in a sample, namely, DNA and RNA screening for medical purposes;
all of the aforesaid services not including medical consultations provided via phone, online or
videoconferencing and providing information about medical test results to patients and medical professionals in the form of reportsClass 044 for Medical services, medical assistance, medical
counseling, healthcare testing, diagnostic testing, and diagnostic tests for personal wellness, namely, in the fields of cancer, blood abnormalities, immune diseases, neurological diseases,
cardiovascular diseases, infectious diseases, viral diseases, genetic diseases, and other tissue-based diagnostic testing, cytology, and cell-based testing; Medical services for the detection and
identification of nucleic acids in a sample, namely, DNA and RNA screening for medical purposes; all of the aforesaid services not including medical consultations provided via phone, online or
videoconferencing and providing information about medical test results to patients and medical professionals in the form of reports
Filing Basis: Section 1(b), Intent to Use: For a trademark or service mark application: As of the application filing date, the applicant had a bona fide intention, and was
entitled, to use the mark in commerce on or in connection with the identified goods/services in the application.
For a collective trademark, collective service mark, or collective membership
mark application: As of the application filing date, the applicant had a bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by members
on or in connection with the identified goods/services/collective membership organization.
For a certification mark application: As of the application filing date, the applicant had a
bona fide intention, and was entitled, to exercise legitimate control over the use of the mark in commerce by authorized users in connection with the identified goods/services, and the applicant will
not engage in the production or marketing of the goods/services to which the mark is applied, except to advertise or promote recognition of the certification program or of the goods/services that
meet the certification standards of the applicant.
The applicant's current attorney information: Julian D. Gonzalez. Julian D. Gonzalez, is located at
1 DEERPARK DRIVE, SUITE R
MONMOUTH JUNCTION, New Jersey 08852
US
The docket/reference number is ESX-T065.
The phone number is 732-274-1020.
The fax number is 732-274-1021.
The email address is esxip@essenlix.com
The applicants proposed attorney information: Julian D. Gonzalez. Julian D. Gonzalez, is a member of the XX bar, admitted to the bar in XXXX, bar membership no. XXX, is located at
1 DEERPARK DRIVE, SUITE R
MONMOUTH JUNCTION, New Jersey 08852
United States
The docket/reference number is ESX-T065.
The phone number is 732-274-1020.
The fax number is 732-274-1021.
The email address is esxip@essenlix.com
Julian D. Gonzalez submitted the following statement: The attorney of record is an active member in good standing of the bar of the highest court of a U.S. state, the District of Columbia, or any
U.S. Commonwealth or territory.
The applicant's current correspondence information: JULIAN D. GONZALEZ. JULIAN D. GONZALEZ, is located at
1 DEERPARK DRIVE, SUITE R
MONMOUTH JUNCTION, New Jersey 08852
US
The docket/reference number is ESX-T065.
The phone number is 732-274-1020.
The fax number is 732-274-1021.
The email address is esxip@essenlix.com; julian_gonzalez@essenlix.com
The applicants proposed correspondence information: Julian D. Gonzalez. Julian D. Gonzalez, is located at
1 DEERPARK DRIVE, SUITE R
MONMOUTH JUNCTION, New Jersey 08852
United States
The docket/reference number is ESX-T065.
The phone number is 732-274-1020.
The fax number is 732-274-1021.
The email address is esxip@essenlix.com; julian_gonzalez@essenlix.com
SIGNATURE(S)
Response Signature
Signature: /Julian D. Gonzalez/ Date: 08/19/2019
Signatory's Name: Julian D. Gonzalez
Signatory's Position: Attorney of Record, New Jersey bar member
Signatory's Phone Number: 732-274-1020
The signatory has confirmed that he/she is a U.S.-licensed attorney who is an active member in good standing of the bar of the highest court of a U.S. state (including the District of Columbia and
any U.S. Commonwealth or territory); and he/she is currently the owner's/holder's attorney or an associate thereof; and to the best of his/her knowledge, if prior to his/her appointment another
U.S.-licensed attorney not currently associated with his/her company/firm previously represented the owner/holder in this matter: the owner/holder has revoked their power of attorney by a signed
revocation or substitute power of attorney with the USPTO; the USPTO has granted that attorney's withdrawal request; the owner/holder has filed a power of attorney appointing him/her in this matter;
or the owner's/holder's appointed U.S.-licensed attorney has filed a power of attorney appointing him/her as an associate attorney in this matter.
Mailing Address: JULIAN D. GONZALEZ
1 DEERPARK DRIVE, SUITE R
MONMOUTH JUNCTION, New Jersey 08852
Mailing Address: Julian D. Gonzalez
1 DEERPARK DRIVE, SUITE R
MONMOUTH JUNCTION, New Jersey 08852
Serial Number: 88205002
Internet Transmission Date: Mon Aug 19 12:08:55 EDT 2019
TEAS Stamp: USPTO/ROA-XX.XXX.XX.XX-20190819120855243
451-88205002-610b6cec1d71a926d5994ef39f4
878385486ff742ef99e95ddf2cde646aba19-N/A
-N/A-20190819105610347836